Cover Image
市場調查報告書

BioArctic Neuroscience AB:產品平台分析

BioArctic Neuroscience AB - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253757
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
BioArctic Neuroscience AB:產品平台分析 BioArctic Neuroscience AB - Product Pipeline Review - 2015
出版日期: 2015年04月29日 內容資訊: 英文 27 Pages
簡介

BioArctic Neuroscience AB 瑞典的斯德哥爾摩在設立總公司生物科技企業,開發著為了神經退化性疾病的新的免疫治療藥。該公司的單株抗體及檢測套件對象免疫組織化學法,酵素免疫分析法,並且免疫印漬術等一樣的檢驗方法有用。產學合作專心致力為還有中樞神經系統疾病的開發治療。

本報告提供BioArctic Neuroscience 提供著AB的治療藥開發平台的現狀及各開發階段比較分析,藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

BioArctic Neuroscience AB的基本資料

  • BioArctic Neuroscience AB概要
  • 主要資訊
  • 企業資料

BioArctic Neuroscience AB:R&D概要

  • 主要的治療範圍

BioArctic Neuroscience AB:開發平台(管線)的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

BioArctic Neuroscience AB:開發中產品概況

  • 臨床實驗階段有的開發中產品
    • 第二階段有的產品/聯合治療模式
  • 初期階段有的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

BioArctic Neuroscience AB:藥物簡介

  • SC-0806
  • BAN-0805
  • BAN-2502
  • AD-1502

BioArctic Neuroscience AB:開發平台分析

  • 按標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

BioArctic Neuroscience AB:最近的開發平台趨勢

BioArctic Neuroscience AB:暫停中的計劃

BioArctic Neuroscience AB:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07032CDB

Summary

Global Markets Direct's, 'BioArctic Neuroscience AB - Product Pipeline Review - 2015', provides an overview of the BioArctic Neuroscience AB's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BioArctic Neuroscience AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of BioArctic Neuroscience AB including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of BioArctic Neuroscience AB's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the BioArctic Neuroscience AB's pipeline products

Reasons to buy

  • Evaluate BioArctic Neuroscience AB's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of BioArctic Neuroscience AB in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the BioArctic Neuroscience AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of BioArctic Neuroscience AB and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of BioArctic Neuroscience AB
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of BioArctic Neuroscience AB and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • BioArctic Neuroscience AB Snapshot
    • BioArctic Neuroscience AB Overview
    • Key Information
    • Key Facts
  • BioArctic Neuroscience AB - Research and Development Overview
    • Key Therapeutic Areas
  • BioArctic Neuroscience AB - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • BioArctic Neuroscience AB - Pipeline Products Glance
    • BioArctic Neuroscience AB - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • BioArctic Neuroscience AB - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • BioArctic Neuroscience AB - Drug Profiles
    • SC-0806
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BAN-0805
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BAN-2502
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AD-1502
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • BioArctic Neuroscience AB - Pipeline Analysis
    • BioArctic Neuroscience AB - Pipeline Products by Target
    • BioArctic Neuroscience AB - Pipeline Products by Route of Administration
    • BioArctic Neuroscience AB - Pipeline Products by Molecule Type
    • BioArctic Neuroscience AB - Pipeline Products by Mechanism of Action
  • BioArctic Neuroscience AB - Recent Pipeline Updates
  • BioArctic Neuroscience AB - Dormant Projects
  • BioArctic Neuroscience AB - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • BioArctic Neuroscience AB, Key Information
  • BioArctic Neuroscience AB, Key Facts
  • BioArctic Neuroscience AB - Pipeline by Indication, 2015
  • BioArctic Neuroscience AB - Pipeline by Stage of Development, 2015
  • BioArctic Neuroscience AB - Monotherapy Products in Pipeline, 2015
  • BioArctic Neuroscience AB - Out-Licensed Products in Pipeline, 2015
  • BioArctic Neuroscience AB - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • BioArctic Neuroscience AB - Phase II, 2015
  • BioArctic Neuroscience AB - Preclinical, 2015
  • BioArctic Neuroscience AB - Discovery, 2015
  • BioArctic Neuroscience AB - Pipeline by Target, 2015
  • BioArctic Neuroscience AB - Pipeline by Route of Administration, 2015
  • BioArctic Neuroscience AB - Pipeline by Molecule Type, 2015
  • BioArctic Neuroscience AB - Pipeline Products by Mechanism of Action, 2015
  • BioArctic Neuroscience AB - Recent Pipeline Updates, 2015
  • BioArctic Neuroscience AB - Dormant Developmental Projects,2015

List of Figures

  • BioArctic Neuroscience AB - Pipeline by Top 10 Indication, 2015
  • BioArctic Neuroscience AB - Pipeline by Stage of Development, 2015
  • BioArctic Neuroscience AB - Monotherapy Products in Pipeline, 2015
  • BioArctic Neuroscience AB - Out-Licensed Products in Pipeline, 2015
  • BioArctic Neuroscience AB - Pipeline by Top 10 Target, 2015
  • BioArctic Neuroscience AB - Pipeline by Top 10 Molecule Type, 2015
  • BioArctic Neuroscience AB - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top